This week the EECO2 team has successfully installed a new MEMU on a client site in Poland. The team is now receiving data in our head office in the UK from the oral solid manufacturing site. The data will be analysed to produce energy consumption information that can be normalised against local temperatures, production and occupation and will help our team to identify the site’s largest energy consuming equipment. The reports and data will be analysed for any inefficiencies within the HVAC system, which will then lead to further energy saving opportunities and projects.
If you are interested in what a MEMU could do for your site, or if you would like to visit our head office for a demonstration get in touch with our team today.
For more information on the MEMU and its uses, visit the MEMU page. This page includes case studies of the MEMU as well as an explaination of how it works and what the dashboard portal looks like.
COVID-19: MANAGING RISK IN PHARMACEUTICAL HVAC SYSTEMS
We’ve updated our document to include additional information and FAQ’s (the basic guidance remains unchanged).
To access the document, visit: https://www.eeco2.com/resources/details/?resource=covid-19-managing-risk-in-pharmaceutical-hvac-systems&id=1867 Any questions, info@eeco2.com
We have created a document with practical advice to assess the risks and recommended appropriate action to minimize the risks associated with airborne transmission of Covid-19 (Novel Coronavirus).
Download the PDF here: http://www.eeco2.com/resources
We have created a document with practical advice to assess the risks and recommended appropriate action to minimize the risks associated with airborne transmission of Covid-19 (Novel Coronavirus).
Download the PDF here: https://lnkd.in/dT9ZvBB
Sign up to the knowledge hub
This site uses cookies to track user interaction and improve your experience on the website. By clicking okay, you are giving your consent to use cookies. Please see our privacy policy for more information and to see how you can manage your consent. Find out more.
